Obstáculos de los biosimilares en EE.UU.

It is projected that women in the United States will spend almost 50 years of their lives taking prescription drugs. The cost of these medications can be painfully high, with 43% of women unable to afford prescriptions at some point. The rising costs of medications, especially for biologics and biosimilars, can pose challenges for patients. Biologics, made from living cells, are often used to treat conditions like cancer and diabetes, but their high cost is a barrier to access. Biosimilars, which are similar copies of biologics, offer a more affordable alternative. Despite the benefits of biosimilars, they can be difficult to find in the US due to patent disputes and lack of insurance coverage. Increasing access to biosimilars can help reduce overall healthcare costs and financial burdens on patients. Various initiatives and legislative efforts are being made to promote the use of biosimilars and make them more widely available. To improve access to biosimilars, patients can educate themselves about these medications and engage in discussions with healthcare providers. Joining patient advocacy groups and sharing experiences can also help raise awareness and promote policies that support broader access to biosimilars.